Favourites   Have ideas?  Sign in / Register

Positive:   Cancer fight ↓0.42   Medicine ↓0.02   Country: Israel 0.00 «See more»   Pharmaceutical  ↑0.88   Disease: Kidney ↑2.98   Dermatology ↑2.98

Negative:


Disease: Liver segment

AKRO Akero Therapeutics, Inc. - Common Stock 4.05% up -15.1% 19.15 + Disease: Liver, Medicine


Last highlighted: #AKRO SEC report: Akero Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Akero Therapeutics, Inc. -- SEC File Number
+ My List
BIVI BioVie Inc. - Common stock -7.72% -7.72% 0 + Medicine, Disease: Liver

+ My List
CARA Cara Therapeutics, Inc. - Common Stock 2.98% up -10.55% 13.53 + Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology


Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat
+ My List
DCTH Delcath Systems, Inc. - Common Stock 2.04% up -7.08% 9.12 + Cancer fight, Medicine, Disease: Liver


Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness
+ My List
DRRX DURECT Corporation - Common Stock 0 + Biopharma, Disease: Liver, Medicine


Last highlighted: $DRRX New Form 8-K for DURECT Corporation From our Stock News Alerts App
+ My List
ETNB 89bio, Inc. - Common Stock up -8.01% 8.01 + Biopharma, Disease: Liver, Medicine

+ My List
GALT Galectin Therapeutics Inc. - Common Stock -2.88% up -7.35% 4.47 + Cancer fight, Disease: Liver, Skin, Medicine


Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679
+ My List
GLMD Galmed Pharmaceuticals Ltd. - Ordinary Shares 0 + Disease: Liver, Biopharma, Country: Israel, Medicine


Last highlighted: Galmed Pharmaceuticals Ltd current quarter revenue growth YoY of 96.40% ranked 256 out of 5424 companies in our database. https://t.co/R7UW3RpPpw $GLMD 🚀🚀🚀🚀🚀 https://t.co/HVbvEgerWf
+ My List
GNFT GENFIT S.A. - American Depositary Shares 0.82% down 23.6% -22.78 + Biopharma, Disease: Liver, Medicine

+ My List
ICPT Intercept Pharmaceuticals, Inc. - Common Stock 0.48% up -9.64% 10.12 + Pharmaceutical , Medicine, Biopharma, Disease: Liver


Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number
+ My List
NDRA ENDRA Life Sciences Inc. - Common Stock 0 + Life Sciences, Disease: Liver

+ My List
TERN Terns Pharmaceuticals, Inc. - Common Stock 1.27% 1.27% 0 + Biopharma, Pharmaceutical , Disease: Liver


Last highlighted: $TERN 8-K Terns Pharmaceuticals (14 Jun, 4:40pm) 📰 Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH https://t.co/wJNwFxLOZw #TERN #8K #TernsPharmaceuticals #News
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.